 Reed Ayers
Concepts (125)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spine | 2 | 2017 | 155 | 1.010 |
Why?
| | Bone Substitutes | 3 | 2017 | 27 | 0.880 |
Why?
| | Prostheses and Implants | 3 | 2017 | 140 | 0.810 |
Why?
| | Hardness | 2 | 2017 | 17 | 0.610 |
Why?
| | Metals | 2 | 2017 | 126 | 0.550 |
Why?
| | Reoperation | 1 | 2017 | 555 | 0.470 |
Why?
| | Materials Testing | 4 | 2017 | 343 | 0.370 |
Why?
| | Titanium | 3 | 2017 | 80 | 0.340 |
Why?
| | Alloys | 3 | 2017 | 35 | 0.320 |
Why?
| | Durapatite | 2 | 1999 | 35 | 0.310 |
Why?
| | Osseointegration | 2 | 1999 | 56 | 0.310 |
Why?
| | Postoperative Complications | 1 | 2017 | 2500 | 0.250 |
Why?
| | Bone Development | 2 | 2003 | 48 | 0.210 |
Why?
| | Bone and Bones | 3 | 2002 | 297 | 0.170 |
Why?
| | Maxilla | 1 | 1998 | 33 | 0.160 |
Why?
| | Skull | 1 | 1999 | 128 | 0.150 |
Why?
| | Chromium | 1 | 2017 | 12 | 0.150 |
Why?
| | Corrosion | 1 | 2017 | 15 | 0.150 |
Why?
| | Ions | 1 | 2017 | 66 | 0.140 |
Why?
| | Cobalt | 1 | 2017 | 52 | 0.140 |
Why?
| | Nickel | 1 | 2017 | 53 | 0.140 |
Why?
| | Pliability | 1 | 2017 | 46 | 0.140 |
Why?
| | Stainless Steel | 1 | 2017 | 24 | 0.140 |
Why?
| | Phosphorus | 1 | 2017 | 92 | 0.140 |
Why?
| | Body Fluids | 1 | 2017 | 61 | 0.140 |
Why?
| | Iron | 2 | 2017 | 285 | 0.140 |
Why?
| | Elastic Modulus | 1 | 2017 | 123 | 0.140 |
Why?
| | Equipment Failure Analysis | 1 | 2017 | 132 | 0.140 |
Why?
| | Prosthesis Failure | 1 | 2017 | 120 | 0.140 |
Why?
| | Spinal Injuries | 1 | 2017 | 53 | 0.130 |
Why?
| | Reference Values | 1 | 2017 | 792 | 0.130 |
Why?
| | Lumbar Vertebrae | 1 | 2017 | 217 | 0.130 |
Why?
| | Skin Diseases | 2 | 2006 | 144 | 0.120 |
Why?
| | Biocompatible Materials | 1 | 1998 | 394 | 0.120 |
Why?
| | Patient-Centered Care | 1 | 2017 | 505 | 0.100 |
Why?
| | Patient Readmission | 1 | 2017 | 675 | 0.100 |
Why?
| | Calcium | 1 | 2017 | 1182 | 0.090 |
Why?
| | Bone Nails | 1 | 2011 | 67 | 0.090 |
Why?
| | Maxillofacial Prosthesis Implantation | 2 | 1999 | 3 | 0.080 |
Why?
| | Porosity | 2 | 1999 | 92 | 0.080 |
Why?
| | Tomography, X-Ray Computed | 1 | 2017 | 2539 | 0.070 |
Why?
| | Fibrosis | 2 | 2007 | 521 | 0.070 |
Why?
| | Contrast Media | 2 | 2007 | 388 | 0.070 |
Why?
| | Gadolinium DTPA | 1 | 2007 | 49 | 0.070 |
Why?
| | Body Piercing | 1 | 2006 | 4 | 0.070 |
Why?
| | Gadolinium | 1 | 2006 | 77 | 0.070 |
Why?
| | Rabbits | 2 | 1999 | 758 | 0.060 |
Why?
| | Granuloma | 1 | 2006 | 89 | 0.060 |
Why?
| | Tibia | 2 | 1998 | 183 | 0.060 |
Why?
| | Dermatitis, Allergic Contact | 1 | 2006 | 70 | 0.060 |
Why?
| | Skin | 2 | 2007 | 737 | 0.060 |
Why?
| | Bone Diseases, Metabolic | 2 | 2003 | 59 | 0.050 |
Why?
| | Treatment Outcome | 1 | 2017 | 10299 | 0.050 |
Why?
| | Bone Resorption | 2 | 2002 | 77 | 0.050 |
Why?
| | Sialoglycoproteins | 1 | 2002 | 156 | 0.050 |
Why?
| | Kidney Failure, Chronic | 1 | 2007 | 548 | 0.050 |
Why?
| | Humans | 8 | 2017 | 129706 | 0.050 |
Why?
| | Aging | 2 | 2003 | 1769 | 0.040 |
Why?
| | Osteoporosis | 1 | 2003 | 233 | 0.040 |
Why?
| | Hindlimb Suspension | 1 | 2000 | 21 | 0.040 |
Why?
| | Multiple Myeloma | 1 | 2002 | 121 | 0.040 |
Why?
| | Aged | 2 | 2017 | 22113 | 0.040 |
Why?
| | Middle Aged | 2 | 2017 | 31103 | 0.040 |
Why?
| | Biomechanical Phenomena | 3 | 1999 | 783 | 0.040 |
Why?
| | Haversian System | 1 | 1998 | 3 | 0.040 |
Why?
| | Cnidaria | 1 | 1998 | 4 | 0.040 |
Why?
| | Maxillary Sinus | 1 | 1998 | 11 | 0.040 |
Why?
| | Femur | 2 | 2003 | 242 | 0.040 |
Why?
| | Humerus | 1 | 1998 | 41 | 0.040 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2000 | 211 | 0.040 |
Why?
| | Bone Remodeling | 1 | 1998 | 71 | 0.040 |
Why?
| | Glycoproteins | 1 | 2000 | 340 | 0.040 |
Why?
| | Surface Properties | 1 | 1999 | 391 | 0.040 |
Why?
| | Osteoblasts | 1 | 1998 | 118 | 0.040 |
Why?
| | Space Flight | 1 | 1998 | 124 | 0.040 |
Why?
| | Animals | 8 | 2003 | 34733 | 0.040 |
Why?
| | Osteogenesis | 1 | 1998 | 191 | 0.030 |
Why?
| | Male | 6 | 2017 | 63544 | 0.030 |
Why?
| | Insulin-Like Growth Factor I | 1 | 1998 | 308 | 0.030 |
Why?
| | Mice, Inbred C57BL | 4 | 2003 | 5279 | 0.030 |
Why?
| | Energy Intake | 1 | 1999 | 460 | 0.030 |
Why?
| | Analysis of Variance | 1 | 1998 | 1288 | 0.030 |
Why?
| | Cats | 1 | 1996 | 211 | 0.030 |
Why?
| | Elasticity | 1 | 1996 | 202 | 0.030 |
Why?
| | Species Specificity | 1 | 1996 | 567 | 0.030 |
Why?
| | Rats | 3 | 2000 | 5244 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 2 | 1998 | 2314 | 0.030 |
Why?
| | Stress, Mechanical | 1 | 1996 | 470 | 0.030 |
Why?
| | Female | 4 | 2017 | 68562 | 0.030 |
Why?
| | Mice | 5 | 2003 | 16585 | 0.020 |
Why?
| | Bone Density | 3 | 2002 | 470 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 1998 | 4939 | 0.020 |
Why?
| | Time Factors | 1 | 1999 | 6593 | 0.020 |
Why?
| | Electron Probe Microanalysis | 1 | 2006 | 3 | 0.020 |
Why?
| | Sampling Studies | 1 | 2007 | 95 | 0.020 |
Why?
| | Body Weight | 2 | 2003 | 935 | 0.020 |
Why?
| | Paraffin Embedding | 1 | 2006 | 28 | 0.020 |
Why?
| | Biopsy, Needle | 1 | 2007 | 192 | 0.020 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2006 | 194 | 0.020 |
Why?
| | Lysosomes | 1 | 2006 | 139 | 0.020 |
Why?
| | Organ Specificity | 1 | 2006 | 296 | 0.020 |
Why?
| | Single-Blind Method | 1 | 2006 | 275 | 0.020 |
Why?
| | Acidosis | 1 | 2006 | 90 | 0.020 |
Why?
| | Renal Insufficiency | 1 | 2006 | 150 | 0.010 |
Why?
| | Diaphyses | 1 | 2003 | 15 | 0.010 |
Why?
| | Mass Spectrometry | 1 | 2007 | 659 | 0.010 |
Why?
| | Calcification, Physiologic | 1 | 2003 | 34 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2007 | 1700 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 2007 | 1849 | 0.010 |
Why?
| | Pilot Projects | 1 | 2006 | 1567 | 0.010 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 1 | 2002 | 252 | 0.010 |
Why?
| | Osteoprotegerin | 1 | 2000 | 24 | 0.010 |
Why?
| | Adolescent | 1 | 1999 | 20355 | 0.010 |
Why?
| | Placebos | 1 | 2000 | 203 | 0.010 |
Why?
| | Hyaluronic Acid | 1 | 2002 | 214 | 0.010 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2000 | 163 | 0.010 |
Why?
| | Kidney | 1 | 2007 | 1330 | 0.010 |
Why?
| | Specific Pathogen-Free Organisms | 1 | 1998 | 60 | 0.010 |
Why?
| | Mice, Inbred BALB C | 1 | 2002 | 1241 | 0.010 |
Why?
| | Weightlessness | 1 | 1998 | 69 | 0.010 |
Why?
| | Interleukin-6 | 1 | 2002 | 715 | 0.010 |
Why?
| | Weight-Bearing | 1 | 1998 | 183 | 0.010 |
Why?
| | Interleukin-1 | 1 | 2002 | 972 | 0.010 |
Why?
| | Risk Assessment | 1 | 2007 | 3297 | 0.010 |
Why?
| | Adult | 1 | 1999 | 35596 | 0.010 |
Why?
|
|
Ayers's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|